Swiss biopharmaceutical company Neovii Pharmaceuticals has promoted its chief commercial officer Juergen Pohle to managing director and CEO.
He will assume the new role in January, when it takes over from outgoing CEO Alexandre Sudarskis who will continue at the firm as an executive director and member of its board.
David Fuhrer said: “Juergen’s leadership skills, his long-term proven track record and his many years of international experience in the pharmaceutical industry make him the ideal candidate for the position of CEO.
“We are extremely pleased that Juergen has embraced the challenge of further driving the development and growth of Neovii.”
Pohle has served as Neovii’s chief commercial officer of Pharmaceuticals since 2016 and has over 25 years of experience in the pharmaceutical industry, having previously worked at Bayer HealthCare, GlaxoSmithKline and Novartis.
Prior to joining Neovii he headed up Novartis’ emerging growth markets and institutional customers businesses.